Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism
Background: Secondary hyperparathyroidism (SHPT) usually requires parathyroidectomy when drug regimens fail. However, obtaining an exact preoperative map of the locations of the parathyroid glands is a challenge. The purpose of this study was to compare the diagnostic performance of US, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in patients with SHPT.
Methods: Sixty patients with SHPT who were undergoing dialysis were evaluated preoperatively by US, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT. Postoperative pathology served as the gold standard. The sensitivity, specificity, and accuracy were determined for each method. Spearman correlation analysis was used to analyse the correlation of hyperplastic parathyroid calcification with serum alkaline phosphatase (ALP) and parathyroid hormone (PTH).
Results: A total of 229 lesions in 60 patients were pathologically confirmed to be parathyroid hyperplasia, with 209 lesions in typical sites, 15 lesions in the upper mediastinum and 5 lesions in the thyroid. A total of 88.33% (53/60) of patients had four lesions. US, early and delayed 99mTc-MIBI SPECT/CT had significantly higher sensitivity and accuracy than dual-phase 99mTc-MIBI scintigraphy (P < 0.001). Furthermore, early 99mTc-MIBI SPECT/CT had significantly higher sensitivity (P < 0.001) and accuracy (P = 0.001 and P < 0.001) than US and delayed 99mTc-MIBI SPECT/CT. In patients with ectopic hyperplastic parathyroid glands, the sensitivity of early 99mTc-MIBI SPECT/CT (90%) was significantly higher than that of US (55%) and dual-phase 99mTc-MIBI scintigraphy (50%) (P < 0.05). The Spearman correlation results showed a significant linear association between calcification and both serum PTH and ALP (P = 0.002).
Conclusion: The ability of early 99mTc-MIBI SPECT/CT to detect hyperplastic parathyroid glands in patients with SHPT is superior to that of US, dual-phase 99mTc-MIBI scintigraphy and delayed 99mTc-MIBI SPECT/CT; furthermore, dual-phase 99mTc-MIBI SPECT/CT is not essential.
Figure 1
Figure 2
Due to technical limitations the Tables are available as downloads in the Supplementary Files.
This is a list of supplementary files associated with this preprint. Click to download.
Posted 23 Jun, 2020
On 03 Aug, 2020
On 22 Jun, 2020
On 21 Jun, 2020
On 21 Jun, 2020
On 10 Jun, 2020
On 10 Jun, 2020
Received 10 Jun, 2020
Invitations sent on 22 May, 2020
On 21 May, 2020
On 20 May, 2020
On 20 May, 2020
On 29 Apr, 2020
Received 26 Apr, 2020
On 20 Apr, 2020
Received 10 Apr, 2020
Invitations sent on 31 Mar, 2020
On 31 Mar, 2020
On 26 Mar, 2020
On 25 Mar, 2020
On 25 Mar, 2020
On 05 Mar, 2020
Received 03 Mar, 2020
Received 19 Feb, 2020
On 17 Feb, 2020
On 08 Feb, 2020
Invitations sent on 07 Feb, 2020
On 24 Jan, 2020
On 23 Jan, 2020
On 23 Jan, 2020
On 23 Jan, 2020
Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism
Posted 23 Jun, 2020
On 03 Aug, 2020
On 22 Jun, 2020
On 21 Jun, 2020
On 21 Jun, 2020
On 10 Jun, 2020
On 10 Jun, 2020
Received 10 Jun, 2020
Invitations sent on 22 May, 2020
On 21 May, 2020
On 20 May, 2020
On 20 May, 2020
On 29 Apr, 2020
Received 26 Apr, 2020
On 20 Apr, 2020
Received 10 Apr, 2020
Invitations sent on 31 Mar, 2020
On 31 Mar, 2020
On 26 Mar, 2020
On 25 Mar, 2020
On 25 Mar, 2020
On 05 Mar, 2020
Received 03 Mar, 2020
Received 19 Feb, 2020
On 17 Feb, 2020
On 08 Feb, 2020
Invitations sent on 07 Feb, 2020
On 24 Jan, 2020
On 23 Jan, 2020
On 23 Jan, 2020
On 23 Jan, 2020
Background: Secondary hyperparathyroidism (SHPT) usually requires parathyroidectomy when drug regimens fail. However, obtaining an exact preoperative map of the locations of the parathyroid glands is a challenge. The purpose of this study was to compare the diagnostic performance of US, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in patients with SHPT.
Methods: Sixty patients with SHPT who were undergoing dialysis were evaluated preoperatively by US, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT. Postoperative pathology served as the gold standard. The sensitivity, specificity, and accuracy were determined for each method. Spearman correlation analysis was used to analyse the correlation of hyperplastic parathyroid calcification with serum alkaline phosphatase (ALP) and parathyroid hormone (PTH).
Results: A total of 229 lesions in 60 patients were pathologically confirmed to be parathyroid hyperplasia, with 209 lesions in typical sites, 15 lesions in the upper mediastinum and 5 lesions in the thyroid. A total of 88.33% (53/60) of patients had four lesions. US, early and delayed 99mTc-MIBI SPECT/CT had significantly higher sensitivity and accuracy than dual-phase 99mTc-MIBI scintigraphy (P < 0.001). Furthermore, early 99mTc-MIBI SPECT/CT had significantly higher sensitivity (P < 0.001) and accuracy (P = 0.001 and P < 0.001) than US and delayed 99mTc-MIBI SPECT/CT. In patients with ectopic hyperplastic parathyroid glands, the sensitivity of early 99mTc-MIBI SPECT/CT (90%) was significantly higher than that of US (55%) and dual-phase 99mTc-MIBI scintigraphy (50%) (P < 0.05). The Spearman correlation results showed a significant linear association between calcification and both serum PTH and ALP (P = 0.002).
Conclusion: The ability of early 99mTc-MIBI SPECT/CT to detect hyperplastic parathyroid glands in patients with SHPT is superior to that of US, dual-phase 99mTc-MIBI scintigraphy and delayed 99mTc-MIBI SPECT/CT; furthermore, dual-phase 99mTc-MIBI SPECT/CT is not essential.
Figure 1
Figure 2
Due to technical limitations the Tables are available as downloads in the Supplementary Files.